Related Experiment Video
Updated: May 5, 2026
10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
4.3K
Inflammation and macular oedema after pars plana vitrectomy
Vito Romano1, Martina Angi, Fabrizio Scotti
1Second University of Naples, Via Pansini 5, 80100 Napoli, Italy.
Mediators of Inflammation
|November 30, 2013
Summary
Cystoid macular oedema (CMO) significantly reduces vision after eye surgery. Intraocular inflammation drives CMO development through intracellular or extracellular fluid shifts, impacting the macula.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Complications
Background:
- Cystoid macular oedema (CMO) is a leading cause of vision loss post-intraocular surgery.
- The exact mechanisms of CMO are not fully understood, but intraocular inflammation is a key factor.
- CMO can manifest as cytotoxic (intracellular) or vasogenic (extracellular) oedema.
Purpose of the Study:
- To elucidate the mechanisms of CMO formation after pars plana vitrectomy.
- To explore associated surgical procedures contributing to CMO.
- To discuss potential therapeutic strategies for managing CMO.
Main Methods:
- Review of literature on CMO pathogenesis.
- Analysis of clinical data related to pars plana vitrectomy outcomes.
- Discussion of inflammatory pathways involved in CMO.
Main Results:
- Pars plana vitrectomy and related surgeries can trigger CMO.
- Both intracellular and extracellular fluid accumulation contribute to macular oedema.
- Inflammation plays a critical role in disrupting the blood-retinal barrier.
Conclusions:
- Understanding CMO mechanisms post-vitrectomy is crucial for vision preservation.
- Targeting intraocular inflammation may offer therapeutic benefits.
- Further research into specific surgical factors and treatments is warranted.
Related Concept Videos
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:27Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K